Description
Fifty-five percent of all people over the age of 55 have,
or are at risk for osteoporosis and the prevalence of osteoporosis
is expected to continue to increase with the growth of the elderly
population. According to the National Institutes of Health (NIH),
osteoporosis leads to 1.5 million fractures per year with the cost
of treatment estimated at $17 billion and rising. Fracture associated
with osteoporosis is very prevalent; one in two women and one in
four men older than 50 will suffer a vertebral fracture.
According to findings at the annual meeting of the North America
Menopause Society (NAMS) in October 2004, many women treated with daily or weekly bisphosphonates do not take their medication regimen as directed. One study indicated that while weekly bisphosphonate treatment lead to greater adherence, it still resulted in a suboptimal dosing regimen. Clearly, compliance continues to be a struggle in this patient population regardless of dosage regimen. Greater education and counseling by pharmacists as the most accessible health care providers across America presents an opportunity to increase patient compliance and potentially enhance therapeutic outcomes in this patient population.
Learning
Objectives
Upon successful completion of this activity, the pharmacist should be better able
to:
- Describe how current prescription treatment options for patients
with osteoporosis are targeting better medication compliance.
- Develop a plan for appropriate calcium and vitamin D intake
for the prevention or treatment of postmenopausal osteoporosis.
- Describe the safety and efficacy of various drug therapies for
the treatment of postmenopausal osteoporosis.
- Determine appropriate drug therapy by using evidence-based medicine.
- Outline the physical and economic ramifications of non-compliance in this patient population.
- Relate key strategies for enhancing patient compliance with osteoporosis therapy.
Target
Audience
Pharmacists
and Pharmacy Technicians
CE
Credit
A score of 70 percent is required to successfully complete
the CE quiz. You will have two opportunities to achieve a passing score. There
is no fee for this program.
The
Statement of Credit should be printed upon receipt; a duplicate
copy
will be available in the participant's online transcript for further
viewing. Individuals must complete this program by June 14,
2009 to receive credit.
NCPA
is approved by the Accreditation Council for Pharmacy
Education as a provider of continuing pharmacy education.
This program will provide 2.0 contact hour(s)
(.2 CEUs) of continuing pharmacy education
credit under the number
207-000-06-084-H01.
Faculty
Information
Lindsey Stephens, R.Ph.
Medicap Pharmacies Inc.
West Des Moines, Iowa
Lindsey Stephens received her Bachelor of Science in Pharmacy
from Drake University in 1998. Upon graduation Lindsey became the owner
of Professional Health Screenings from 1998 to 1999. Previously, she
was the co-owner and manager of Premier Health in Urbandale, Iowa.
Lindsey is an active member of state and national pharmacy organizations
and has served at both the state and national level on policy setting
committees. Ms. Stephens is currently the President of Medihealth Solutions
in West Des Moines, Iowa.
Laura Hansen, PharmD, FCCP, BCPS
Assistant Professor
Clinical Pharmacy and Family Medicine
University of Colorado at Denver and Health Sciences Center
Denver, Colorado
Dr. Laura Hansen received her BS in Pharmacy from the University
of Iowa in 1995 and her Pharm.D. from the University of Colorado in 1997. Following her formal education, she pursued a one-year primary care residency at the University of Colorado Health Sciences Center and Kaiser Permanente. She received her Board Certification in Pharmacotherapy in the fall of 1998.
Before returning to the University of Colorado where she is now employed, she was involved in developing disease management programs in community pharmacies in Virginia as a faculty member for Shenandoah University.
Faculty
Disclosure Statements
NCPA has a conflict of interest policy that requires course
faculty to disclose any real or apparent commercial financial affiliations
related to the content of their presentations/materials.
Commercial
Support
Commercial Support provided by Roche Laboratories Inc. and GlaxoSmithKline.
  |
Software
Requirements
